Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects

doi:10.3389/fmicb.2018.02888

CNU IR > Pharmacy and Science > Dept. of Health and Nutrition (including master's program) > Periodical Articles > Item 310902800/32320

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32320

Title:	Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
Authors:	Jean, Shio-Shin Lee, Nan-Yao Tang, Hung-Jen Lu, Min-Chi Ko, Wen-Chien Hsueh, Po-Ren
Contributors:	Taipei Med Univ, Dept Emergency, Sch Med, Coll Med Taipei Med Univ, Dept Emergency Med, Wan Fang Hosp Taipei Med Univ, Dept Emergency & Crit Care Med, Wan Fang Hosp Natl Cheng Kung Univ, Dept Internal Med, Med Coll & Hosp Chi Mei Med Ctr, Dept Med Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr China Med Univ, Dept Microbiol & Immunol, Sch Med Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Coll Med
Keywords:	carbapenem-resistant Enterobacteriaceae carbapenemase Klebsiella pneumoniae Escherichia coli long-term care facility tigecycline colistin avibactam
Date:	2018-11-27
Issue Date:	2019-12-16 09:35:31 (UTC+8)
Publisher:	FRONTIERS MEDIA SA
Abstract:	Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control. Many investigations have shown a high association of CRE infections with high case-fatality rates. In Taiwan, a few surveys observed that a significant proportion (29-47%) of the CR-Klebsiella pneumoniae isolates harbored a plasmidic allele encoding K. pneumoniae carbapenemases (KPC, especially KPC-2). A significant increase in the number of oxacillinase (OXA)-48-like carbapenemases among CR-K. pneumoniae isolates was observed between 2012 and 2015. By striking contrast, isolates of CR-Escherichia coli and CR-Enterobacter species in Taiwan had a much lower percentage of carbapenemase production than CR-K. pneumoniae isolates. This differs from isolates found in China as well as in the India subcontinent. Apart from the hospital setting, CRE was also cultured from the inpatients from communities or long-term care facilities (LTCF). Therefore, implementation of regular CRE screening of LTCF residents, strict disinfectant use in nursing homes and hospital settings, and appropriate control of antibiotic prescriptions is suggested to alleviate the spread of clinical CRE isolates in Taiwan. Although there are some promising new antibiotics against CRE, such as ceftazidime-avibactam, meropenem-vaborbactam, aztreonam-avibactam and cefiderocol, these agents are not available in Taiwan currently. Therefore, in order to effectively decrease case-fatality rates among patients with the infections owing to carbapenemase-producing CRE isolates, combination antibiotic schemes, including colistin (or amikacin) and/or tigecycline in combination with an anti-pseudomonal carbapenem agent, remain the mainstay for treating clinical CRE infections.
???metadata.dc.relation.uri???:	http://dx.doi.org/10.3389/fmicb.2018.02888
Relation:	Nova Hedwigia, v.9, 2888
Appears in Collections:	[Dept. of Health and Nutrition (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
10.3389-fmicb.2018.02888.pdf		492Kb	Adobe PDF	488	View/Open
index.html		0Kb	HTML	1499	View/Open

Loading...